Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

164

currently held

Exits tracked

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-09-23

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change1 week ago

Caledonia Investments1 week ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Elaia PartnersadminCEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway2 weeks ago

Elaia Partners2 weeks ago

CEO change · Departure of CEO Gire, Philippe · CEO departure · leadership transition underway

admin

Lauxera Capital PartnersadminBoard change · Management board member change: et Directeur général délégué Fracchia, Edoardo · Change in the management board1 month ago

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
Rondo Therapeutics2 periods Novo Holdings Venture Investments	Biotech	United States	Novo Holdings	2022	4yr	Active	–	–
Accipiter Biosciences Columbus Life Sciences Fund IV	Biotech	United States	Columbus Venture Partners	2025	1yr	Active	–	–
AcousticaBio Vento Fund I	Biotech	United States	Vento	2023	3yr	Active	–	–
Aeovian Pharmaceuticals Apollo Health Ventures Fund I	Biotech	United States	Apollo Health Ventures	2019	7yr	Active	–	–
Aleta Biotherapeutics Columbus Life Sciences Fund IV	Biotech	United States	Columbus Venture Partners	2024	2yr	Active	–	–
AnaBios Principia III - Health	Biotech	United States	Principia SGR	2016	10yr	Active	–	–
ArsenalBio Hitachi Ventures Fund II	Biotech	United States	Hitachi Ventures	2022	4yr	Active	–	–
Artax Biopharma Columbus Innvierte Life Science Fund I	Biotech	United States	Columbus Venture Partners	2020	6yr	Active	–	–
Arzeda Sofinnova Industrial Biotech	Biotech	United States	Sofinnova Partners	2022	4yr	Active	–	–
Auron Therapeutics Apollo Health Ventures Fund II	Biotech	United States	Apollo Health Ventures	2022	4yr	Active	–	–
Catamaran Bio Sofinnova Capital X	Biotech	United States	Sofinnova Partners	2022	4yr	Active	–	–
Celea Therapeutics Leaps by Bayer	Biotech	United States	Leaps by Bayer	2026	0yr	Active	–	–
Cellino Biotech Leaps by Bayer	Biotech	United States	Leaps by Bayer	2022	4yr	Active	–	–
Cerevance Dementia Discovery Fund	Biotech	United States	SV Health Managers	2016	10yr	Active	–	–
Cyclarity Therapeutics KIZOO Evergreen (Balance Sheet)	Biotech	United States	KIZOO Technology Capital	2019	7yr	Active	–	–
Dermala Health for Life Capital	Biotech	United States	Seventure Partners	2020	6yr	Active	–	–
Elastrin Therapeutics KIZOO Evergreen (Balance Sheet)	Biotech	United States	KIZOO Technology Capital	2021	5yr	Active	–	–
EpiBone EMV Capital Evergreen Fund	Biotech	United States	EMV Capital	2020	6yr	Active	–	–
Federation Bio Health for Life Capital	Biotech	United States	Seventure Partners	2022	4yr	Active	–	–
Foodsmart Health for Life Capital	Biotech	United States	Seventure Partners	2021	5yr	Active	–	–
Gemma Biotherapeutics Earlybird Health	Biotech	United States	Earlybird Venture Capital	2024	2yr	Active	–	–
Gordian 10x Founders Fund I	Biotech	United States	10x Founders	2021	5yr	Active	–	–
HotSpot Therapeutics Sofinnova Capital IX	Biotech	United States	Sofinnova Partners	2019	7yr	Active	–	–
Ilios Therapeutics Vento Fund I	Biotech	United States	Vento	2023	3yr	Active	–	–
Indapta Therapeutics Leaps by Bayer	Biotech	United States	Leaps by Bayer	2022	4yr	Active	–	–
Jurata Thin Film Columbus Life Sciences Fund IV	Biotech	United States	Columbus Venture Partners	2022	4yr	Active	–	–
Kamau Therapeutics Neva II	Biotech	United States	Neva SGR	2024	2yr	Active	–	–
Kano Therapeutics Vsquared Ventures II	Biotech	United States	Vsquared Ventures	2024	2yr	Active	–	–
Karius Sport & Performance Capital	Biotech	United States	Seventure Partners	2020	6yr	Active	–	–
KCAS Vitruvian Investment Partnership IV	Biotech	United States	Vitruvian Partners	2021	5yr	Active	–	–
KG Bio General Atlantic Portfolio	Biotech	United States	General Atlantic	–	–	Active	–	–
Khloris Biosciences Leaps by Bayer	Biotech	United States	Leaps by Bayer	2019	7yr	Active	–	–
Kula Bio AgFunder Fund IV	Biotech	United States	AgFunder	–	–	Active	–	–
Lepure Biotech General Atlantic Portfolio	Biotech	United States	General Atlantic	–	–	Active	–	–
Longevity Biotech EMV Capital Evergreen Fund	Biotech	United States	EMV Capital	2014	12yr	Active	–	–
Mimetic Medicines AgFunder Fund IV	Biotech	United States	AgFunder	–	–	Active	–	–
Modern Meadow Evonik Venture Capital	Biotech	United States	Evonik Venture Capital	2019	7yr	Active	–	–
Mosanna HTGF IV	Biotech	United States	High-Tech Gruenderfonds (HTGF)	2023	3yr	Active	–	–
Myco Technology Health for Life Capital	Biotech	United States	Seventure Partners	2020	6yr	Active	–	–
nChroma (formerly Chroma Medicine) Sofinnova Telethon	Biotech	United States	Sofinnova Partners	2022	4yr	Active	–	–
Nested Therapeutics TVM Life Science Ventures	Biotech	United States	TVM Capital Life Science	2022	4yr	Active	–	–
NextPoint Therapeutics Leaps by Bayer	Biotech	United States	Leaps by Bayer	2023	3yr	Active	–	–
Nitrase Therapeutics Sofinnova Capital IX	Biotech	United States	Sofinnova Partners	2020	6yr	Active	–	–
Nurix Therapeutics General Atlantic Growth Equity Fund	Biotech	United States	General Atlantic	–	–	Active	–	–
Paratus Sciences Leaps by Bayer	Biotech	United States	Leaps by Bayer	2023	3yr	Active	–	–
Pow.Bio Hitachi Ventures Fund III	Biotech	United States	Hitachi Ventures	2023	3yr	Active	–	–
Prometheus Materials Sofinnova Industrial Biotech	Biotech	United States	Sofinnova Partners	2022	4yr	Active	–	–
PureTech Vitruvian Investment Partnership IV	Biotech	United States	Vitruvian Partners	2020	6yr	Active	–	–
Quince Therapeutics (formerly EryDel) Sofinnova Capital IX	Biotech	United States	Sofinnova Partners	2019	7yr	Active	–	–
QurAlis Dementia Discovery Fund	Biotech	United States	SV Health Managers	2020	6yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.